These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 18053672)

  • 21. An overview of analytical methodologies for the determination of antibiotics in environmental waters.
    Seifrtová M; Nováková L; Lino C; Pena A; Solich P
    Anal Chim Acta; 2009 Sep; 649(2):158-79. PubMed ID: 19699391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).
    Borman PJ; Chatfield MJ; Crowley EL; Eckers C; Elder DP; Francey SW; Laures AM; Wolff JC
    J Pharm Biomed Anal; 2008 Dec; 48(4):1082-9. PubMed ID: 18835674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of LC-MS for the analysis of cleaning verification samples.
    Simmonds EL; Lough WJ; Gray MR
    J Pharm Biomed Anal; 2006 Feb; 40(3):631-8. PubMed ID: 16311001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of trace level genotoxic impurities in small molecule drug substances using conventional headspace gas chromatography with contemporary ionic liquid diluents and electron capture detection.
    Ho TD; Yehl PM; Chetwyn NP; Wang J; Anderson JL; Zhong Q
    J Chromatogr A; 2014 Sep; 1361():217-28. PubMed ID: 25151038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous separation and determination of coenzyme Q(10) and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS).
    Nageswara Rao R; Kumar Talluri MV; Shinde DD
    J Pharm Biomed Anal; 2008 Jun; 47(2):230-7. PubMed ID: 18243624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification, control strategies, and analytical approaches for the determination of potential genotoxic impurities in pharmaceuticals: a comprehensive review.
    Reddy AV; Jaafar J; Umar K; Majid ZA; Aris AB; Talib J; Madhavi G
    J Sep Sci; 2015 Mar; 38(5):764-79. PubMed ID: 25556762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development.
    Dobo KL; Greene N; Cyr MO; Caron S; Ku WW
    Regul Toxicol Pharmacol; 2006 Apr; 44(3):282-93. PubMed ID: 16464524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analytical applications of liquid phase chemiluminescence reactions--a review.
    Bowie AR; Sanders MG; Worsfold PJ
    J Biolumin Chemilumin; 1996; 11(2):61-90. PubMed ID: 8726582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of differential scanning calorimetry for the purity verification of pharmaceutical reference standards.
    Mathkar S; Kumar S; Bystol A; Olawoore K; Min D; Markovich R; Rustum A
    J Pharm Biomed Anal; 2009 Apr; 49(3):627-31. PubMed ID: 19186017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
    Castro-Perez JM
    Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance evaluation of evaporative light scattering detection and charged aerosol detection in reversed phase liquid chromatography.
    Vervoort N; Daemen D; Török G
    J Chromatogr A; 2008 May; 1189(1-2):92-100. PubMed ID: 18054946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of electron capture detection in reversed-phase HPLC for pharmaceutical analysis.
    Pereira AS; Szucs R; Sandra P
    J Sep Sci; 2009 Jan; 32(1):29-33. PubMed ID: 19051192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High throughput screening of active pharmaceutical ingredients by UPLC.
    Al-Sayah MA; Rizos P; Antonucci V; Wu N
    J Sep Sci; 2008 Jul; 31(12):2167-72. PubMed ID: 18563754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical process research and development in the 21st century: challenges, strategies, and solutions from a pharmaceutical industry perspective.
    Federsel HJ
    Acc Chem Res; 2009 May; 42(5):671-80. PubMed ID: 19338294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

  • 36. Transfer of analytical procedures: a panel of strategies selected for risk management, with emphasis on an integrated equivalence-based comparative testing approach.
    Agut C; Caron A; Giordano C; Hoffman D; Ségalini A
    J Pharm Biomed Anal; 2011 Sep; 56(2):293-303. PubMed ID: 21700410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sub-2 microm HPLC coupled with sub-ppm mass accuracy for analysis of pharmaceutical compound libraries.
    Stroh JG; Petucci CJ; Brecker SJ; Nogle LM
    J Sep Sci; 2008 Dec; 31(21):3698-703. PubMed ID: 18925622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass spectrometry analysis of new chemical entities for pharmaceutical discovery.
    Fang AS; Miao X; Tidswell PW; Towle MH; Goetzinger WK; Kyranos JN
    Mass Spectrom Rev; 2008; 27(1):20-34. PubMed ID: 18033735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a sensitive method for alkyl sulfonate genotoxic impurities determination in drug substances using gas chromatography coupled to triple quadrupole mass spectrometry.
    Liu Z; Fan H; Zhou Y; Qian X; Tu J; Chen B; Duan G
    J Pharm Biomed Anal; 2019 May; 168():23-29. PubMed ID: 30784886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eliminating pharmaceutical impurities: Recent advances in detection techniques.
    Liu DQ; Sun M; Wu L
    Curr Opin Drug Discov Devel; 2010; 13(6):748-57. PubMed ID: 21061235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.